SFDA has permitted clinical trials for the therapy of systemic lupus erythematosus using human umbilical cord-derived mesenchymal stem cells.
Nikkei Biotech, July 10, 2014
SFDA has permitted clinical trials for the therapy of systemic lupus erythematosus using human umbilical cord-derived mesenchymal stem cells.
Nikkei Biotech, July 10, 2014
This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.
Accept or Deny